Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Vanda Pharmaceuticals Inc. (VNDA)

Now, key money managers were leading the bulls’ herd. OrbiMed Advisors, managed by Samuel Isaly, assembled the most valuable call position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). OrbiMed Advisors had $12.5 million invested in the company at the end of the quarter. Steve Cohen’s Point72 Asset Management also initiated a $9 million position during the quarter. The following funds were also among the new VNDA investors: Ken Greenberg and David Kim’s Ghost Tree Capital, Glenn Russell Dubin’s Highbridge Capital Management, and Ken Griffin’s Citadel Investment Group.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) but similarly valued. We will take a look at Live Oak Bancshares Inc (NASDAQ:LOB), Barnes & Noble Education Inc (NYSE:BNED), Albany Molecular Research, Inc. (NASDAQ:AMRI), and Greenhill & Co., Inc. (NYSE:GHL). All of these stocks’ market caps match VNDA’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
LOB 4 7326 -2
BNED 14 94174 -2
AMRI 13 93179 1
GHL 16 106468 6

As you can see these stocks had an average of 11.75 hedge funds with bullish positions and the average amount invested in these stocks was $75 million. That figure was $321 million in VNDA’s case. Greenhill & Co., Inc. (NYSE:GHL) is the most popular stock in this table. On the other hand Live Oak Bancshares Inc (NASDAQ:LOB) is the least popular one with only 4 bullish hedge fund positions. Compared to these stocks Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers and growing fonder of it still, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...